NKGEN BIOTECH INC (NKGN)

US65488A1016 - Common Stock

1.12  -0.01 (-0.88%)

After market: 1.1 -0.02 (-1.79%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.00
Cost Of Goods
0.00N/AN/AN/A
Gross Profit
0.00N/AN/AN/A
Operating Expenses
29.75M2.74M2.51MN/A
Research and Development
15.67MN/AN/AN/A
Selling, General, and Administrative Expenses
14.08M2.74M2.51MN/A
Operating Income
-29.75M-2.74M-2.51M0.00
Interest Income/Expense
-48.95M7.55M5.71MN/A
Other Income/Expense
-923.00K180.00K-4.19MN/A
Non Recurring Items
-3.33MN/AN/AN/A
Income Before Taxes
-82.95M4.99M-990.00KN/A
Income Tax
7.00K440.00KN/AN/A
Net Income
-82.95M4.55M-990.00KN/A
EBITDA
-28.54MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-5.380.21-0.07N/A
 
Statistics

All data in USD

Charts